Nov 4, 2026 07:46AM
Nov 4, 2026 07:00AM
Aug 10, 2026 08:04AM
Aug 10, 2026 07:00AM
Aug 10, 2026 07:00AM
May 11, 2026 06:29AM
May 10, 2026 09:00AM MoonLake receives FDA alignment on sonelokimab BLA submission plans
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
Feb 22, 2026 11:00AM
Feb 22, 2026 11:00AM
Nov 5, 2025 07:00AM MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab
Aug 5, 2025 07:49AM
Aug 5, 2025 07:00AM
May 27, 2025 06:40AM
May 13, 2025 06:47AM
May 12, 2025 04:00PM
Apr 12, 2025 04:00AM
Feb 26, 2025 07:00AM MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Nov 7, 2024 07:00AM
Aug 7, 2024 08:00AM
May 7, 2024 04:21PM
May 7, 2024 08:00AM
Feb 29, 2024 08:00AM
Feb 29, 2024 08:00AM
Nov 14, 2023 04:10PM MoonLake Immunotherapeutics (MLTX) Tops Q3 EPS by 5c
Nov 14, 2023 08:00AM
Aug 10, 2023 07:00AM
May 12, 2023 07:45AM
Mar 20, 2023 07:45AM
Mar 20, 2023 07:45AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM MoonLake Immunotherapeutics Reports Third Quarter 2022 Financial Results and Provides Recent Business Update

1,239,981 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All